- Home
- GANX vs EEA Comparison
GANX vs EEA Comparison
Compare GANX & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GANX | EEA |
|---|---|---|
| Founded | 2017 | 1986 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.5M | 73.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GANX | EEA |
|---|---|---|
| Price | $1.75 | $10.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 792.5K | 30.2K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | ★ 31.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $55,180.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.41 | $9.62 |
| 52 Week High | $4.34 | $11.43 |
Technical Indicators
Market Signals| Indicator | GANX | EEA |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 49.55 |
| Support Level | $1.66 | $10.57 |
| Resistance Level | $2.09 | $11.07 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 60.00 | 27.93 |
Price Performance
Historical ComparisonAbout GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.